Share

Trials show AstraZeneca COVID-19 vaccine ‘highly effective’

British drugmaker AstraZeneca has said the COVID-19 vaccine it’s developed with the University of Oxford is 70 per cent effective on average. The vaccine is one of several that Canada has already preordered and is considered more globally accessible.

Watch The National live on YouTube Sunday-Friday at 9 p.m. ET

Subscribe to The National:
https://www.youtube.com/user/CBCTheNational?sub_confirmation=1

Connect with The National online:
Facebook | https://www.facebook.com/thenational
Twitter | https://twitter.com/CBCTheNational
Instagram | https://www.instagram.com/cbcthenational

More from CBC News | https://www.cbc.ca/news

The National is CBC’s flagship nightly news program, featuring the day’s top stories with in-depth and original journalism, with hosts Adrienne Arsenault and Andrew Chang in Toronto, Ian Hanomansing in Vancouver and the CBC’s chief political correspondent, Rosemary Barton in Ottawa.

Leave a Comment